Twist Bioscience (TWST) Other financing activities (2017 - 2026)

Twist Bioscience (TWST) has reported Other financing activities for 10 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other financing activities rose 131.74% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $7.7 million (down 9.87% YoY), while the FY2025 annual figure was $9.3 million, up 31.59% from the prior year.
• Other financing activities grew to $1.8 million in Q1 2026 per TWST's latest filing, from $300000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $266.7 million in Q1 2022 and bottomed at -$263.8 million in Q3 2022.
• Historically, Other financing activities has averaged $1.3 million across 5 years, with a median of $951000.0 in 2023.
• Annual changes were most pronounced in 2022 — Other financing activities surged 8083.03% — and 2023, when it slumped 99.91%.
• Twist Bioscience's Other financing activities stood at $604000.0 in 2022, then jumped by 57.45% to $951000.0 in 2023, then jumped by 210.2% to $2.9 million in 2024, then tumbled by 89.83% to $300000.0 in 2025, then soared by 496.33% to $1.8 million in 2026.
• Business Quant data shows TWST's Other financing activities at $1.8 million in Q1 2026, $300000.0 in Q4 2025, and $3.8 million in Q3 2025.